Improved blood pressure control with nocturnal hemodialysis: Review of clinical observations and physiologic mechanisms

Current Hypertension Reports

Volumn 6, Issue 2, 2004, Pages 140-144

  McCormick, Brendan B ^a   Chan, Christopher T ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NEUROHORMONE; RENIN;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR SYSTEM; CIRCADIAN RHYTHM; GEOMETRY; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HEMODYNAMICS; HOME CARE; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MORBIDITY; MORTALITY; QUALITY OF LIFE; REVIEW; SLEEP APNEA SYNDROME; SURVIVAL RATE; SYMPATHETIC TONE; UREMIA; BLOOD PRESSURE; HEART VENTRICLE REMODELING; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RENAL REPLACEMENT THERAPY;

BLOOD PRESSURE; CIRCADIAN RHYTHM; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; KIDNEY TRANSPLANTATION; RENAL DIALYSIS; UREMIA; VENTRICULAR REMODELING;

EID: 4644226746     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-004-0090-9     Document Type: Review

References (30)

1. Pierratos A, Ouwendyk M, Francoeur R, et al.: Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol 1998, 9:859-868.
2. Kooistra MP: Frequent prolonged home haemodialysis: three old concepts, one modern solution. Nephrol Dial Transplant 2003, 18:16-19.
3. Suri R, Depner TA, Blake PG, et al.: Adequacy of quotidian hemodialysis. Am J Kidney Dis 2003, 42 (Suppl1 : 2-48.
4. Pierratos A: Nocturnal home haemodialysis: an update on a 5 year experience. Nephrol Dial Transplant 1999, 14: 835-2840.
5. Brissenden JE, Pierratos A, Ouwendyk M, et al.: Improvement in quality of life with nocturnal hemodialysis [abstract]. J Am Soc Nephrol 1998, 9:168A.
6. Musci I, Hercz G, Uldall R, et al.: Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 1998, 53:1399-1404.
7. Hardy PJ, Pierratos A: Improvement in sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 2001, 344:102-107.
8. Saleem MM: Hypertension in the hemodialysis population: a survey of 649 patients. Am J Kidney Dis 1995, 26:461-468.
9. London GM: Controversy on optimal blood pressure on haemodialysis: lower is not always better. Nephrol Dial Transplant 2001, 16:476-478.
10. Tomita J, Kimura G, Inoue T, et al.: Role of systolic blood pressure in determining prognosis of hemodialyzed patients. Am J Kidney Dis 1995, 25:405-412.
11. Lynn KL, McGregor DO, Moesbergen T, et al.: Hypertension as a determinant of survival for patients treated with home dialysis. Kidney Int 2002, 62:2281-2287.
12. Silberberg JS, Barre PE, Prichard SS, Sniderman AD: Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989, 36:286-290.
13. Laurent G: How to keep the dialysis patients normotensive? What is the secret of Tassin? Nephrol Dial Transplant 1997, 12:1104.
14. Innes A, Charra B, Burden RP, et al.: The effect of long, slow haemodialysis on patient survival. Nephrol Dial Transplant 1999, 14:919-922.
15. Fagugli RM, Reboldi G, Quintaliani G, et al.: Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 2001, 38:371-376.
16. Chan CT, Floras JS, Miller JA, et al.: Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 2002, 61:2235-2239.
17. Chan C, Floras JS, Miller JA, Pierratos A: Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure. Nephrol Dial Transplant 2002, 17:1518-1521.
18. Lindsay RM, Leitch R, Heidenheim AP, Kortas C: The London daily/nocturnal hemodialysis study: study design, morbidity and mortality results. Am J Kidney Dis 2003, 42(Suppl 1):5-12.
19. NIH seeking applications for short daily, nocturnal dialysis trial. Nephrol News Issues 2003, 17:30-31.
20. Chan CT, Harvey PJ, Picton P, et al.: Short-term blood pressure, noradrenergic, and vascular effects of nocturnal home hemodialysis. Hypertension 2003, In press.
21. Converse RL, Jacobsen TN, Toto RD, et al.: Sympathetic over-activity in patients with chronic renal failure. N Engl J Med 1992, 327:1912-1918.
22. Leung RS, Bradley TD: Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 2001, 164:2147-2165.
23. Chan CT, Hanly P, Gabor J, et al.: Impact of nocturnal hemodialysis on the variability of heart rate and duration of hypoxemia during sleep. Kidney Int 2003, In press.
24. Morris STW, McMurray JJV, Rodger RSC, Jardine AG: Impaired endothelium dependent vasodilatation in uraemia. Nephrol Dial Transplant 2000, 15:1194-1200.
25. Cross JM, Donald A, Vallance PJ, et al.: Dialysis improves endothelial function in humans. Nephrol Dial Transplant 2001, 16:1823-1829.
26. Wolfe RA, Ashby VB, Milford EL, et al.: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999, 341:1725-1730.
27. Fontan MP, Rodriguez-Carmona A, Bouza P, et al.: Delayed graft function after renal transplantation in patients undergoing peritoneal dialysis and hemodialysis. Adv Perit Dial 1996, 12:101-104.
28. McCormick BB, Pierratos A, Fenton S, et al.: Review of clinical outcomes in nocturnal hemodialysis patients after renal transplantation. Nephrol Dial Transplant 2003, In press.
29. Scherrer U, Vissing SF, Morgan BJ, et al.: Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990, 323:693-699.
30. Morris ST, McMurray JJ, Rodger RS, et al.: Endothelial dysfunction in renal transplant recipients maintained on cyclosporine. Kidney Int 2000, 57:1100-1106.